Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Beta Drugs IPO and Shreeji Translogistics IPO.
Beta Drugs IPO is a SME Fixed Price Issue IPO proposed to list at NSE SME while Shreeji Translogistics IPO is a SME Fixed Price Issue proposed to list at BSE SME.
| Beta Drugs IPO | Shreeji Translogistics IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price Issue | Fixed Price Issue |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Pantomath Capital Advisors Pvt Ltd | Aryaman Financial Services Limited |
| Registrar | Link Intime India Private Ltd | Bigshare Services Pvt Ltd |
| Market Maker | ||
| DRHP | ||
| RHP | RHP  |
RHP |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Beta Drugs IPO is up to ₹19.52 Cr whereas the issue size of the Shreeji Translogistics IPO is up to ₹12.40 Cr. The final issue price of Beta Drugs IPO is ₹85.00 per share and of Shreeji Translogistics IPO is ₹130.00 per share.
| Beta Drugs IPO | Shreeji Translogistics IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹85.00 per share | ₹130.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 1000 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 22,96,000 shares | 9,54,000 shares |
| Issue Size Total (Amount) | up to ₹19.52 Cr | up to ₹12.40 Cr |
Beta Drugs IPO opens on Sep 29, 2017, while Shreeji Translogistics IPO opens on Sep 29, 2017. The closing date of Beta Drugs IPO and Shreeji Translogistics IPO is Oct 04, 2017, and Oct 05, 2017, respectively.
| Beta Drugs IPO | Shreeji Translogistics IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Sep 29, 2017 | Sep 29, 2017 |
| Issue Close | Oct 04, 2017 | Oct 05, 2017 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Beta Drugs IPO P/E ratio is , as compared to Shreeji Translogistics IPO P/E ratio of .
| Beta Drugs IPO | Shreeji Translogistics IPO | |
|---|---|---|
| Financial | ||
| Promoter Shareholding (Pre-Issue) | ||
| Promoter Shareholding (Post-Issue) | ||
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW |
In the Beta Drugs IPO retail investors (RII) are offered while in Shreeji Translogistics IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Beta Drugs IPO and in Shreeji Translogistics IPO.
| Beta Drugs IPO | Shreeji Translogistics IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | ||
| NII | ||
| RII | ||
| Employee | ||
| Others | ||
| Total |
Beta Drugs IPO subscribed in total, whereas Shreeji Translogistics IPO subscribed .
| Beta Drugs IPO | Shreeji Translogistics IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
